Pfm Health Sciences, LP Equillium, Inc. Transaction History

Pfm Health Sciences, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$3.0 - $5.0 $3.19 Million - $5.32 Million	-1,064,979 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$3.31 - $5.6 $1.14 Million - $1.94 Million	-345,853 Reduced 24.51%	1,064,979 $4.05 Million
Q2 2019 Aug 14, 2019	SELL	$5.28 - $8.2 $190,819 - $296,348	-36,140 Reduced 2.5%	1,410,832 $7.99 Million
Q1 2019 May 15, 2019	BUY	$5.84 - $12.02 $543,032 - $1.12 Million	92,985 Added 6.87%	1,446,972 $11.6 Million
Q4 2018 Feb 14, 2019	BUY	$6.32 - $19.44 $8.56 Million - $26.3 Million	1,353,987 New	1,353,987 $11 Million

11.5M

38.1K

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $47.1M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.